Loading the player...


INFO:
Georgiamune Inc. has gained FDA clearance for its IND application for GIM-531, a first-in-class oral regulatory T cell (Treg) inhibitor that enables the restoration of a strong immune response against cancer.
Georgiamune’s Treg inhibitor GIM-531 gains FDA clearance to enter clinic | BioWorld